These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25008941)

  • 1. Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T cells.
    Jackson SE; Mason GM; Okecha G; Sissons JG; Wills MR
    J Virol; 2014 Sep; 88(18):10894-908. PubMed ID: 25008941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Cytomegalovirus (HCMV)-Specific CD4
    Jackson SE; Sedikides GX; Mason GM; Okecha G; Wills MR
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.
    Gibson L; Piccinini G; Lilleri D; Revello MG; Wang Z; Markel S; Diamond DJ; Luzuriaga K
    J Immunol; 2004 Feb; 172(4):2256-64. PubMed ID: 14764694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease.
    Sacre K; Carcelain G; Cassoux N; Fillet AM; Costagliola D; Vittecoq D; Salmon D; Amoura Z; Katlama C; Autran B
    J Exp Med; 2005 Jun; 201(12):1999-2010. PubMed ID: 15967826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
    Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
    J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.
    Calarota SA; Chiesa A; Scaramuzzi L; Adzasehoun KM; Comolli G; Mangione F; Esposito P; Baldanti F
    J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytomegalovirus UL23 exploits PD-L1 inhibitory signaling pathway to evade T cell-mediated cytotoxicity.
    Yuan Q; Fan Z; Huang W; Huo X; Yang X; Ran Y; Chen J; Li H
    mBio; 2024 Jul; 15(7):e0119124. PubMed ID: 38829126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of cytomegalovirus-specific T-cell response in allogeneic hematopoietic stem cell recipients: the contribution of six frequently recognized, virus-encoded ORFs.
    Nemeckova S; Krystofova J; Babiarova K; Hainz P; Musil J; Sroller V; Maly M; Stastna-Markova M
    Transpl Infect Dis; 2016 Jun; 18(3):381-9. PubMed ID: 27061389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling Human Cytomegalovirus-Specific T Cell Responses Reveals Novel Immunogenic Open Reading Frames.
    Dhanwani R; Dhanda SK; Pham J; Williams GP; Sidney J; Grifoni A; Picarda G; Lindestam Arlehamn CS; Sette A; Benedict CA
    J Virol; 2021 Oct; 95(21):e0094021. PubMed ID: 34379494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.
    Jouand N; Bressollette-Bodin C; Gérard N; Giral M; Guérif P; Rodallec A; Oger R; Parrot T; Allard M; Cesbron-Gautier A; Gervois N; Charreau B
    PLoS Pathog; 2018 Apr; 14(4):e1007041. PubMed ID: 29709038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Paradigmatic Interplay between Human Cytomegalovirus and Host Immune System: Possible Involvement of Viral Antigen-Driven CD8+ T Cell Responses in Systemic Sclerosis.
    Arcangeletti MC; Maccari C; Vescovini R; Volpi R; Giuggioli D; Sighinolfi G; De Conto F; Chezzi C; Calderaro A; Ferri C
    Viruses; 2018 Sep; 10(9):. PubMed ID: 30231575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Control of Human Cytomegalovirus (HCMV) Infection in HCMV-Seropositive Solid Organ Transplant Recipients: The Predictive Role of Different Immunological Assays.
    Zavaglio F; Cassaniti I; d'Angelo P; Zelini P; Comolli G; Gregorini M; Rampino T; Del Frate L; Meloni F; Pellegrini C; Abelli M; Ticozzelli E; Lilleri D; Baldanti F
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequencies cytomegalovirus pp65(495-503)-specific CD8+ T cells in healthy young and elderly Chinese donors: characterization of their phenotypes and TCR Vbeta usage.
    He XH; Zha QB; Liu Y; Xu LH; Chi XY
    J Clin Immunol; 2006 Sep; 26(5):417-29. PubMed ID: 16850281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.
    Sacre K; Nguyen S; Deback C; Carcelain G; Vernant JP; Leblond V; Autran B; Dhedin N
    J Virol; 2008 Oct; 82(20):10143-52. PubMed ID: 18684826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4
    Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T
    Front Immunol; 2018; 9():1129. PubMed ID: 29887865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays.
    Liu A; Ma Y; Wu W; Chen X; Huang Y; Hu J; Liang H; Wang H; Yang R; Fan J
    J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.
    Elkington R; Walker S; Crough T; Menzies M; Tellam J; Bharadwaj M; Khanna R
    J Virol; 2003 May; 77(9):5226-40. PubMed ID: 12692225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cytomegalovirus-specific CD8(+) T-cell expansions contain long-lived cells that retain functional capacity in both young and elderly subjects.
    Wallace DL; Masters JE; De Lara CM; Henson SM; Worth A; Zhang Y; Kumar SR; Beverley PC; Akbar AN; Macallan DC
    Immunology; 2011 Jan; 132(1):27-38. PubMed ID: 20738423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8(+) T cell response.
    Wills MR; Okecha G; Weekes MP; Gandhi MK; Sissons PJ; Carmichael AJ
    J Immunol; 2002 Jun; 168(11):5455-64. PubMed ID: 12023339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the HCMV-Specific CD4 T Cell Responses that Are Associated with Protective Immunity.
    Wunsch M; Zhang W; Hanson J; Caspell R; Karulin AY; Recks MS; Kuerten S; Sundararaman S; Lehmann PV
    Viruses; 2015 Aug; 7(8):4414-37. PubMed ID: 26258786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.